Veeva Systems (NYSE:VEEV)

CAPS Rating: 4 out of 5

Results 1 - 10 of 10

Recs

0
Member Avatar FrankoJames (93.70) Submitted: 12/14/2014 5:07:19 AM : Outperform Start Price: $29.39 VEEV Score: -9.42

Please note that my friends might be typing on this laptop during poker parties, please keep cameras on me illegally so that I know that this CAPS account if protected from cyber scam artists, just kidding. This company is the cloud version of CRM for the pharmaceutical industry, Hearthstone jokes aside. If anyone is worried about spy wars, such as in the 007 movies, you might like researching a company called PANW and yes, I just bought a bear at...

Recs

0
Member Avatar DLester78 (73.81) Submitted: 9/29/2014 5:59:55 PM : Outperform Start Price: $28.89 VEEV Score: -8.62

Drugs trials are bad um kay?

Recs

0
Member Avatar tes1900 (< 20) Submitted: 9/24/2014 9:22:54 PM : Outperform Start Price: $29.22 VEEV Score: -8.99

I see connections to certain other industries - good potential

Recs

1
Member Avatar TMFTypeoh (82.50) Submitted: 9/13/2014 6:41:41 AM : Outperform Start Price: $31.25 VEEV Score: -15.09

simon erickson piggyback

Recs

0
Member Avatar mjjm1976 (< 20) Submitted: 5/23/2014 11:37:43 PM : Outperform Start Price: $21.26 VEEV Score: +22.15

I like the technicals at this level. The vision of the company is strong, and they are innovating outside of the Salesforce platform, but I am buying solely on technicals. The stock bounced up from what looks like rock bottom at $17.11 I have been buying since that level and believe $22 is the next resistance level. After than I am a holder with a stop-loss at $21, which eyes on $26.

Recs

0

Recs

0
Member Avatar sobek1 (< 20) Submitted: 12/24/2013 12:09:51 AM : Outperform Start Price: $33.39 VEEV Score: -32.46

Cloud services is the way of the future, buy this stock on the pull back.

Recs

3
Member Avatar TMFInnovator (42.90) Submitted: 12/9/2013 11:34:05 AM : Outperform Start Price: $38.20 VEEV Score: -41.28

- Life sciences is an industry that requires lots of regulated documentation. This is the perfect opportunity for a cloud-based SaaS company like Veeva.
- CEO and co-founder is Peter Gassner, who was previously senior vice president of Salesforce.com. Gassner was directly responsible for building the salesforce platform. He knows what he's doing and has a proven track record.
- IPO was in October and this company is still under-the-radar. Putting in the thumbs up before Wall Street catches on.
- The company has already attracted big clients. They already have 33 of the 50 largest pharmaceutical companies as customers. They have grown their customer list at 59%/yr for the past two years.

Will keep an eye on: 1) # of new users, 2) acquisition costs per new user, and 3) average revenue per user (ARPU).

There's lots of growth ahead for Veeva. Outperform.

Recs

1
Member Avatar karlsmq (< 20) Submitted: 11/22/2013 3:28:08 PM : Outperform Start Price: $38.25 VEEV Score: -41.92

very interesting business model,it is profitable and growing at high rate .

Recs

1
Member Avatar dubsac (52.11) Submitted: 11/6/2013 6:03:15 PM : Outperform Start Price: $38.64 VEEV Score: -44.69

Only viable cloud for pharmaceutical and biotech industries.

Results 1 - 10 of 10

Featured Broker Partners


Advertisement